- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Union Health Minister releases first commercial batch of Covaxin
"Released the first commercial batch of COVAXIN from Bharat Biotech's plant at Ankleshwar, Gujarat today. This will increase the supply of vaccine in the country and will help the vaccine reach every Indian," Mandaviya said on social media.
New Delhi: The Union Health Minister Mansukh Mandaviya on Sunday released the first commercial batch of Covaxin from the new plant of Bharat Biotech at Ankleshwar in Gujarat's Bharuch district.
"Vaccination is the most important thing to strengthen the country's fight against coronavirus. Released the first commercial batch of #COVAXIN from Bharat Biotech's plant at Ankleshwar, Gujarat today. This will increase the supply of vaccine in the country and will help the vaccine reach every Indian," Mandaviya said on social media.
Also Read: DCGI likely to approve Covaxin for kids prior trial period
In May, Bharat Biotech had announced that it planned to produce an additional 200 million doses of Covaxin at its subsidiary Ankleshwar-based facility.
India's vaccination coverage against coronavirus under the mass vaccination drive has crossed the landmark of 63 crore. Over 73 lakh doses have been administered in the last 24 hours.
However, India reported a total of 45,083 new Covid-19 cases and 460 deaths in the last 24 hours, according to the health ministry's data. The active caseload in the country stands at 3,68,558. The surge in daily Covid cases has been driven by a recent spike in Kerala, which accounts for more than half of all the active Covid-19 cases in the country, followed closely by Maharashtra.
Also Read: Bharat Biotech, IVI begin Chikungunya vaccine Phase 2, 3 trial in Costa Rica
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.